Major Investor Group Reduces Stake Below 5% Threshold

summarizeSummary

Jefferson River Capital LLC and affiliated entities, including Hamilton E. James, have reduced their beneficial ownership in Renalytix plc below the 5% reporting threshold, signaling a decreased stake in the company.

check_boxKey Events

• Ownership Reduction

  Jefferson River Capital LLC and its affiliated entities, including Hamilton E. James, reported reducing their beneficial ownership in Renalytix plc to 4.5% (or 4.4%) of the Ordinary Shares outstanding.

• Below 5% Threshold

  The reporting persons ceased to be beneficial owners of more than 5% of the Ordinary Shares as of November 3, 2025, triggering this Schedule 13D/A amendment.

• Significant Investor Exit

  This marks a notable reduction in stake by a previously significant investor group, potentially signaling a shift in their investment thesis or a strategic partial exit.

auto_awesomeAnalysis

This Schedule 13D/A filing indicates that a significant investor group, led by Jefferson River Capital LLC and Hamilton E. James, has reduced its beneficial ownership in Renalytix plc to 4.5% (or 4.4% for some entities) of the outstanding Ordinary Shares. This reduction below the 5% threshold, which occurred on November 3, 2025, suggests a strategic decision to decrease their exposure to the company. While the exact value of shares sold is not disclosed, crossing this reporting threshold implies a material disposition. This move by a previously significant investor, especially with the stock trading near its 52-week lows, could be interpreted as a negative signal regarding their long-term conviction in the company's prospects.